000 | 01179nam a2200169Ia 4500 | ||
---|---|---|---|
008 | 140223b2004 xxu||||| |||| 00| 0 eng d | ||
020 |
_a9780896038882 _c0.00 |
||
082 |
_a616.994 _bDRU |
||
245 | _aDrug Delivery Systems in Cancer Therapy | ||
260 |
_aNew Jersey _bHumana Press _c2004 |
||
300 | _a390p | ||
500 | _aLeading experts survey the currently available technologies designed to improve the delivery of today's cancer chemotherapeutic agents. The authors review both the theoretical and practical considerations governing conventional and nonconventional methods of drug administration, and identify promising opportunities for product development. In their outline and discussion of the use of novel formulation technologies-including synthetic polymers and biomaterials for prolonged or sustained drug release to achieve potentially greater therapeutic effect-they profile those technologies that have resulted in a number of approved and late-stage clinical products. | ||
600 |
_aCancer _919550 |
||
700 |
_aBrown, Dennis M. _eEditor _919551 |
||
942 |
_2ddc _cLB _k616.994 _mDRU |
||
995 |
_aPharmacy Reference _eP0006193 _j616.994 _yP0006193 |
||
999 |
_c15377 _d15377 |